As the 2021 virtual J.P. Morgan Healthcare Conference wrapped up, BioSpace reviewed news from companies regarding their deals, pipeline and regulatory updates.

BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.

At the 2021 virtual JP Morgan Healthcare Conference, Vertex Pharmaceuticals’ chief executive officer Reshma Kewalramani said the company is looking to buy “mid- and late-stage assets.”

Immunity from Moderna Inc.’s Covid-19 vaccine should last at least a year, the company said at the J.P. Morgan Healthcare conference.

Initially traced to about 100 cases of Covid-19 that spread across the United States, the number of infections linked to a Biogen corporate conference held in February 2020 at the Boston Marriott Long Wharf Hotel has grown exponentially and researchers estimate the total could be as many as 300,000.

After capturing record-breaking attendance at its spring Illuminate event, the Healthcare Businesswomen’s Association (HBA) brought together – virtually – the biggest Annual Conference crowd in the group’s history with more than 1,600 attendees from 15 countries representing 250 healthcare and life science companies.

With global attention on gender and racial inequities this year, the Healthcare Businesswomen’s Association (HBA) is proud to recognize BD (Becton, Dickinson and Company) GSK, Surgical Care Affiliates and Walgreens Boots Alliance with 2020 ACE Awards for exemplary workplace initiatives that are working to close the gender and racial inequities in the healthcare and life sciences industry.

After attending several virtual scientific conferences since the start of the COVID-19 lockdown, TBWA\WorldHealth explores which practices should stay, which ones will need to come back, and how pharmaceutical brands can stand out in this medium.

A review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.

Decentralized clinical trials gained a foothold in the pharmaceutical industry amidst the COVID-19 pandemic and will continue to be used once the pandemic ends, according to panelists at BIO 2020.